|
3. Summary of Significant Accounting Policies (Details 4) (USD $)
|
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
|
Jun. 30, 2013
|
Jun. 30, 2012
|
Jun. 30, 2013
|
Jun. 30, 2012
|
|
| Summary Of Significant Accounting Policies Details 4 | ||||
| Research and development | $ 667 | $ 3,508 | $ 5,503 | $ 6,125 |
| Selling and marketing | 523 | 3,669 | 4,192 | 6,783 |
| General and administrative | 7,787 | 4,045 | 18,322 | 7,182 |
| Total stock-based compensation expense | $ 8,977 | $ 11,222 | $ 28,017 | $ 20,090 |
| X | ||||||||||
|
- Definition
Custom Element. No definition available.
|
| X | ||||||||||
|
- Definition
Custom Element. No definition available.
|
| X | ||||||||||
|
- Definition
Custom Element. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|